In Vitro Studies of Water-Stable Cationic Carbosilane Dendrimers As Delivery Vehicles for Gene Therapy Against HIV and Hepatocarcinoma

Here we present a synthetic procedure for water-stable carbosilane dendrimers containing ammonium groups at the periphery of type Gn-{[Si(CH2)3N+(Me)(Et)CH2CH2N+Me3]x (CF3SO3 -)y} which have been used as non-viral vectors for transfecting different types of nucleic acids against two different medica...

Descripción completa

Detalles Bibliográficos
Autores: Cuevas, Natividad de las, García Gallego, Sandra|||0000-0001-6112-0450, Rasines Moreno, Beatriz, Mata de la Mata, Francisco Javier de la|||0000-0003-0418-3935, González Guijarro, Luis Alberto|||0000-0003-4979-2136, Muñoz Fernández, María Ángeles, Gómez Ramírez, Rafael|||0000-0001-6448-2414
Tipo de recurso: artículo
Fecha de publicación:2012
País:España
Institución:Universidad de Alcalá (UAH)
Repositorio:e_Buah Biblioteca Digital Universidad de Alcalá
Idioma:inglés
OAI Identifier:oai:ebuah.uah.es:10017/67704
Acceso en línea:http://hdl.handle.net/10017/67704
https://dx.doi.org/10.2174/0929867311209025052
Access Level:acceso abierto
Palabra clave:Dendrimer
Carbosilaneo
Ligonucleotides
SiRNA
Drug delivery
Gene therapy
Transfection agent
HIVcancer
Química
Chemistry
Descripción
Sumario:Here we present a synthetic procedure for water-stable carbosilane dendrimers containing ammonium groups at the periphery of type Gn-{[Si(CH2)3N+(Me)(Et)CH2CH2N+Me3]x (CF3SO3 -)y} which have been used as non-viral vectors for transfecting different types of nucleic acids against two different medical problems, HIV and hepatocarcinoma. These systems have shown to be non-toxic in both PBMC and HepG2 cell lines under the experimental conditions and are able to form nanoconjugates with nucleic acids perfectly stable over time and in a wide range of pH values, which leads to the conclusion that the interaction between dendrimer and nucleic acid is very strong. In addition, a high degree of transfection using these nanoconjugates has been observed, ranging from 70-90% depending on the generation and in the particular case of PBMC transfection with anti-HIV oligonucleotides. However, besides of the good properties shown by the dendrimers here prepared as transfecting agents, only moderate effect was observed in functional experiments for hepatocarcinoma, as a result of the strong interaction between dendrimer and nucleic acid. Nevertheless, it is important to mention that an IRS-4 knock-down of 40% in HepG2 achieves an analogous degree of cell sensitization to cancer treatment, which may represent a major advance in the hepatocarcinoma treatment when appropriate dendrimers as transfection agents are used.